Skip Navigation


NDT Plus Advance Access originally published online on June 30, 2008
NDT Plus 2008 1(5):377; doi:10.1093/ndtplus/sfn096
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/5/377    most recent
sfn096v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Xydakis, D.
Right arrow Articles by Sfyridakh, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

The effect of angiotensin type 1 receptor blockade on adhesion molecules in patients with IgA nephropathy

Dimitris Xydakis1, Apostolos Papadogiannakis1, Maria Sfakianaki1, Konstantinos Kostakis1 and Aikaterinh Sfyridakh2

1 Nephrology Department
2 Regional Blood Bank Center Venizeleio Hospital Heraklio Crete, Greece

Correspondence: E-mail: dxydakis@gmail.com

The first 10% of the full text of this article appears below.

Sir,

Various studies have linked inflammation and endothelial dysfunction in patients with chronic renal disease [1]. Plasma levels of adhesion molecules [soluble intracellular adhesion molecule-1 (sICAM) and soluble vascular adhesion molecule-1 (sVCAM)] are markers of endothelial dysfunction and also risk factors for cardiovascular disease in patients with IgA nephropathy (IgAN) [2]. It . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?